Improved prognosis for infants with stage IV neuroblastoma.
From 1970 to 1982 11 infants with Evans stage IV neuroblastoma who were 11 months of age or less at diagnosis were treated. All but one were treated with intensive multiagent chemotherapy; eight had attempted surgical resection; only one received radiotherapy to the primary tumor. Ten of the 11 infants remain free of disease from 2 1/2 to 13 years (median, four years). Multiagent chemotherapy has clearly improved the outcome for infants with stage IV neuroblastoma.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D005729:Ganglioneuroma / Q000556:secondary / Q000601:surgery / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D009918:Orbital Neoplasms / Q000532:radiotherapy / Q000556:secondary; D011379:Prognosis